| abstract |
This invention relates to neuropeptide Y (NPY) receptor agonist peptides and the use of such peptides for therapeutic purposes. The peptides of the present invention are useful in reducing body weight and/or modulation of appetite or caloric intake, thereby providing a treatment option for those individuals afflicted with metabolic disorders such as obesity, type 2 diabetes, eating disorders, insulin-resistance syndrome (Syndrome X), impaired glucose tolerance (IGT), dyslipidemia, and cardiovascular disorders. |